Patient
SITE001-0099
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE001 (USA) (Dr. Reyes)
consented 2025-12-25
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
mild
assessed
2026-07-04
Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-12-28 (study day 177); relationship: not assessed
severe
assessed
2026-03-06
Grade 3 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-08-30 (study day 57); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.